InsideArbitrage Event Driven Monitor – September 1, 2023

Subscribe to receive our Event Driven Monitor by email every morning before the market opens.

Merger Arbitrage

1. ACER: Acer Therapeutics (ACER) by Zevra Therapeutics (ZVRA) for $91 million in an all stock deal. Under the terms of the definitive agreement, at closing, Zevra would issue 0.121 of a share of Zevra’s common stock in respect of each share of Acer’s common stock.
2. FOCS: Clayton, Dubilier & Rice, LLC completed the acquisition of Focus Financial Partners (FOCS).
3. PRDS: MediPacific completed the acquisition of Pardes Biosciences, Inc. (PRDS).

Only plus or premium subscribers can access this post. Subscribe today.